Company: BNRG
Filing Date: 2025-05-14
Form Type: 424B4
Source: 0001213900-25-042979
Chunk: 12

Company: Brenmiller Energy Ltd.
Filing Date: 2025-05-14
Form: 424B4
Chunk 12
---
 the requirements of Regulation FD (Fair
Disclosure) promulgated under the Exchange Act. In addition, as a foreign private issuer, we are permitted to follow certain home country
corporate governance practices instead of those otherwise required under the Nasdaq Stock Market LLC, or the Nasdaq Stock Market, rules
for domestic U.S. issuers. See “Risk Factors—Risks Related to this Offering and the Ownership of our Ordinary Shares and Warrants.” These exemptions and leniencies will reduce the frequency and scope of information and protections available to you
in comparison to those applicable to a U.S. domestic reporting company. We intend to take advantage of the exemptions available to us
as a foreign private issuer during and after the period we qualify as an “emerging growth company.”

<div align='center'>4</div>

THE OFFERING

| Ordinary Shares currently issued and outstanding      |     | 8,806,619 Ordinary Shares                                                                                                                   |
| Ordinary Shares offered by us                         |     | 2,307,693 Ordinary Shares                                                                                                                   |
| Warrants offered by us                                |     | Series                                                                                                                                      
 B Warrants to purchase 2,307,693 Ordinary Shares and Series C Warrants to purchase 2,307,693 Ordinary Shares. This prospectus also          
 relates to the offering of the Ordinary Shares issuable upon exercise of the Warrants. Each Warrant will be exercisable beginning on        
 the date of issuance at an exercise price of $0.75 per Ordinary Share. The Series B Warrants will expire five years from the Initial        
 Exercise Date and the Series C warrants will expire 12 months from the Initial Exercise Date.                                               |
| Ordinary Shares to be outstanding after this offering |     | 11,114,312 Ordinary Shares (assuming none of the Warrants issued in this offering are exercised).                                           |
| Use of proceeds                                       |     | We expect to receive approximately $1.5 million in gross proceeds from                                                                      
 the sale of Ordinary Shares and accompanying Warrants offered by us in this offering, based upon a combined public offering price of $0.65  
 per Ordinary Share and accompanying Warrants, before deducting the placement agent fees and commissions and estimated offering expenses     
 payable by us.                                                                                                                              
 Since this is a best efforts offering with no                                                                                               
 minimum number of securities or amount of proceeds as a condition to closing, and we may not sell all or any of these securities offered    
 pursuant to this prospectus, we may resultantly receive significantly less in net proceeds.